A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241)

NCT01471340 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

11744

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Mometasone Furoate/Formoterol MDI 100/5 mcg
DRUG: Mometasone Furoate/Formoterol MDI 200/5 mcg
DRUG: Mometasone Furoate MDI 100 mcg
DRUG: Mometasone Furoate MDI 200 mcg
DRUG: Albuterol 90 mcg /salbutamol 100 mcg HFA MDI
DRUG: Prednisone/prednisolone

Sponsor

Organon and Co